ProShares Trust (J40E) Cotización

Remember this:

OilFieldServices.AI is currently evaluating multiple acquisition targets and strategic partnerships with over 10 Oil Field Services companies contracted that are generating over $220.0M in combined trailing 12 month revenue.

Josh has also mentioned at ano

Emini Barry >
https://www.youtube.com/watch?v=xh_TyNBq7Q8

You and me both. I hate to do it, but selling my NVDA to increase my position here.

Yes more attacks! Religiously attack BioAmber shareholders even on SUNDAY (the Lord's day)

Xoxo

Major updates coming up

One last thing, Astra Zeneca is in a two part acquisition of Immune Pharmaceuticals using Alexion as the purchaser. That transaction still needs to finalize. Let’s cross our fingers.

Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) entered into an asset purchase agreement to acquire cer

The text from the IRAS User Guide refers to handling Requests for Further Information (RFI) within the review process for clinical research applications, such as clinical trials and medical devices. IRAS is used to submit research applications and obtain ethical approvals, with RFIs potentially rais

Yeah man that's true. I'm looking at all the pure scams y'all have been in right now.

When will you people learn?

Never?

That is odd. I had posted 3 or 4 times this morning, then you came on and said it was just you and cap. (Queue the Twilight Zone music).

I'll probably wait awhile before dealing with the orchids. If the storm gets real close, I will bring them all into my garage. Vanda is still hol

We will see who is going to lose big and go broke soon.

Cellectis that is now controlled by Astra Zeneca is also a great candidate to merge with someone. Astra Zeneca is quietly taking control of everything. As we all know, Astra also has a collaboration with Cytovia Therapeutics which has a partnership with Cellectis using the Talen cell editing tech th

I feel sorry for them. I really do. Why not become an investor who can help the company trying to deliver treatment that potentially can cure for all cancers, and make the world a better place in the meantime get rich? Where else can one find such an opportunity?

Ya I think his $5 to $10 per share is based on 2025 and beyond projections. Which I will admit, are pretty aggressive but if you get the influx of capital needed and make proper moves for expansion that time frame of 12 to 18 months as well as uplisting to the NASDAQ could make those share prices ob

Sadly, your whole post is spot on.

The hardcore extreme longs are a mafia like bunch of persons.

If you dare go against them, you are a fudster working for the MMs.

Thankfully, a small group don't really care but take a much more balanced view, but still

I hope you are right

no buying - no selling for years now --- in my accounts

IMO - as always - I believe step one can be an executive branch action to kill the LP/SP obligation

That could take PPS to 10 IMO with nothing else happening as reserves would

What new management? They scurried like rats.

Bill I agree, please do not through figures around that are in the Docs I provided. 1,000 is the face value for the supplied Docs . I think the $10,000 came from the Series nn. Please stay away from predicting amounts. Just look at the docs for real.

This is very important and when yo

Deficits Are Bullish for Gold
By: Tom McClellan | October 4, 2024

pbs.twimg.com/media/GZI5xPfXYAAIAYi?format=jpg&name=large

This chart looks at the reported deficit, as opposed to the actual change in total debt, and it is expressed as a percentage of GDP.

idiot, didKramerNakedShort🟩4Bill+$DBMM shares4Charity?🟩


Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
https://investorshub.advfn.com/uimage/uploads/2023/1

MB, To coincide with the issuance of new COOP shares for legacy ?

Cohen is bringing some much-needed transparency. OTC is notorious for CEOs that you hear nothing from. Love this guy…though I could take it without the f-bombs - but he’s passionate about what he does. I like that.

Thanks---been a nightmare with another headin' our way...

In my head, I believe, INVO Bioscience that has merged with Naya Bioscience which is a controlled sub of Cytovia Therapeutics ( controlled sub of Immune ) is not going to complete anything this October even though it would be smart to get it terminated, delisted and deregistered prior to financing o